Fundraising Fox

Scott Byrd

Investor

Entrepreneur-in-Residence at Frazier Life Sciences · Executive Officer, Director at Sudo Bio

Indianapolis

Find your path to Scott

109 people in our graph share verified history with Scott — schools, employers, funds. One of them is your warm intro.

Christopher GagliardiunlockedScott: together at Sudo Bio (2023–2026)
×8Scott: together at Frazier Life Sciences
×3Scott: together at Bradley University

About

Scott Byrd is an Entrepreneur-in-Residence at Frazier Life Sciences, which he joined in May 2020, and has more than 25 years of pharmaceutical industry experience. He was previously CEO of Outpost Medicine and President and COO of Acacia Pharma, Inc., and earlier served as SVP and Chief Commercial Officer of Cadence Pharmaceuticals, where he led the launch of OFIRMEV. He began his career in a range of roles at Eli Lilly and holds a B.S. in mechanical engineering from Bradley University and an M.B.A. from Harvard Business School.

Invests in

Biotech

Executive Officer, Director at Sudo Bio

Intro paths

In turn, Scott can intro founders to Sudo Bio's investors below.

Experience

  1. Sudo BiosciencesChief Executive Officercurrent2021 — present
  2. Frazier Life SciencesEntrepreneur In Residencecurrent2020 — present
  3. AlgoTxBoard Member2021 — 2025Paris, France
  4. ACACIA PHARMA GROUP LIMITEDChairman Of The Board2020 — 2022Cambridge, United Kingdom
  5. Outpost MedicinePresident & CEO2017 — 2021Indianapolis, Indiana Area
  6. Acacia Pharma Inc.COO, President - Acacia Pharma Inc.2015 — 2017Indianapolis, Indiana Area
  7. SAB Strategic Advisors LLCPresident, CEO2014 — 2015
  8. Cadence PharmaceuticalsSVP, Chief Commercial Officer2009 — 2014
  9. Eli Lilly and CompanyUS and Global Brand Leader - Cardiovascular and Critical Care1992 — 2009

Skills & more

Pharmaceutical Sales61Marketing Strategy8

From Scott's professional profile.

Investments

Board seats

Acacia Pharma Group plc

Per the firm's website.

Colleagues at Frazier Life Sciences

Frequently asked questions

Who is Scott Byrd?
Scott Byrd is an Entrepreneur-in-Residence at Frazier Life Sciences, which he joined in May 2020, and has more than 25 years of pharmaceutical industry experience. He was previously CEO of Outpost Medicine and President and COO of Acacia Pharma, Inc., and earlier served as SVP and Chief Commercial Officer of Cadence Pharmaceuticals, where he led the launch of OFIRMEV. He began his career in a range of roles at Eli Lilly and holds a B.S. in mechanical engineering from Bradley University and an M.B.A. from Harvard Business School.
Where does Scott Byrd work?
Scott Byrd is Entrepreneur-in-Residence at Frazier Life Sciences.
What does Scott Byrd invest in?
Scott Byrd invests in Biotech.
What boards does Scott Byrd sit on?
Scott Byrd holds tracked board seats at Acacia Pharma Group plc.
Where did Scott Byrd go to school?
Scott Byrd studied at Harvard Business School (MBA); Bradley University (BSME, Mechanical Engineering).

Founder mafias

Same school

Shared employers